Cargando…

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A(2) and Prostaglandin D(2) Receptor Antagonist: A Four-Patient Case Series Report

Hypoxemia in COVID-19 pneumonia is associated with hospitalization, mechanical ventilation, and mortality. COVID-19 patients exhibit marked increases in fatty acid levels and inflammatory lipid mediators, predominantly arachidonic acid metabolites, notably thromboxane B(2) >> prostaglandin E(2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogletree, Martin L., Chander Chiang, Kate, Kulshrestha, Rashmi, Agarwal, Aditya, Agarwal, Ashutosh, Gupta, Ajay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355466/ https://www.ncbi.nlm.nih.gov/pubmed/35935851 http://dx.doi.org/10.3389/fphar.2022.904020

Ejemplares similares

Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor
por: Chakraborty, Raja, et al.
Publicado: (2014)

Ramatroban as a Novel Immunotherapy for COVID-19
por: Gupta, Ajay, et al.
Publicado: (2020)

The effect of ramatroban on cytokine and thrombotic storms in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Prostaglandin D(2) as a mediator of lymphopenia and a therapeutic target in COVID-19 disease
por: Gupta, Ajay, et al.
Publicado: (2020)

Prostaglandin cyclooxygenase products but not thromboxane A(2) are involved in the pathogenesis of ewthromelalgia in thrombocythaemia
por: Michiels, J. J., et al.
Publicado: (1993)

Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats
por: Lagier, David, et al.
Publicado: (2019)

Thromboxane A(2) receptor contributes to the activation of rat pancreatic stellate cells induced by 8-epi-prostaglandin F(2α)
por: Zhang, Xiao-Li, et al.
Publicado: (2020)

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer
por: Watkins, Gareth, et al.
Publicado: (2005)

Inhibitory Effects of Acetylmelodorinol, Chrysin and Polycarpol from Mitrella kentii on Prostaglandin E(2) and Thromboxane B(2) Production and Platelet Activating Factor Receptor Binding
por: Saadawi, Sakina, et al.
Publicado: (2012)

NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
por: Mulvaney, Eamon P., et al.
Publicado: (2020)

An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis
por: Pal, Saumen, et al.
Publicado: (2006)

Inhibiting breast cancer by targeting the thromboxane A(2) pathway
por: Li, Haitao, et al.
Publicado: (2017)

Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice
por: Li, Zhenhua, et al.
Publicado: (2017)

Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.
por: Kasahara, K., et al.
Publicado: (1996)

In Vitro Effect of 3D Plates Used for Surgical Treatment of Condylar Fractures on Prostaglandin E(2) (PGE(2)) and Thromboxane B(2) (TXB(2)) Concentration in THP-1 Macrophages
por: Sikora, Maciej, et al.
Publicado: (2017)

Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994)

Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)

Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury
por: Yan, Aijuan, et al.
Publicado: (2016)

Thromboxane A(2) receptor antagonist (ONO‐8809) attenuates renal disorders caused by salt overload in stroke‐prone spontaneously hypertensive rats
por: Nagatani, Yusuke, et al.
Publicado: (2021)

Synthesis, Stability, and Biological Studies of Fluorinated Analogues of Thromboxane A(2)
por: Jing, Changcheng, et al.
Publicado: (2020)

Urinary 11‐Dehydro‐Thromboxane B(2) as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
por: Szczeklik, Wojciech, et al.
Publicado: (2016)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009)

Investigation of a Thromboxane A(2) Receptor–Based Vaccine for Managing Thrombogenesis
por: Alshbool, Fatima Z., et al.
Publicado: (2018)

Measurement of Thromboxane Biosynthesis in Health and Disease
por: Patrono, Carlo, et al.
Publicado: (2019)

Contribution of Thromboxane A(2) in Rat Common Carotid Artery Response to Serotonin
por: Radenković, Miroslav, et al.
Publicado: (2010)

The Role and Regulation of Thromboxane A(2) Signaling in Cancer-Trojan Horses and Misdirection
por: Ashton, Anthony W., et al.
Publicado: (2022)

Effects of Fatty Acid Metabolites on Adipocytes Britening: Role of Thromboxane A2
por: Colson, Cécilia, et al.
Publicado: (2023)

Thromboxane A(2) is a key regulator of pathogenesis during Trypanosoma cruzi infection
por: Ashton, Anthony W., et al.
Publicado: (2007)

Foetal vascular responses to thromboxane receptor blockade
por: Meyer, B. A., et al.
Publicado: (1992)

Prostacyclin and thromboxane in benign and malignant breast tumours.
por: Laekeman, G. M., et al.
Publicado: (1986)

Regulation of the Tumor Suppressor FOXO3 by the Thromboxane-A(2) Receptors in Urothelial Cancer
por: Sobolesky, Philip M., et al.
Publicado: (2014)

Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013)

Thromboxane A(2) exacerbates acute lung injury via promoting edema formation
por: Kobayashi, Koji, et al.
Publicado: (2016)

Role for the thromboxane A(2) receptor β-isoform in the pathogenesis of intrauterine growth restriction
por: Powell, Katie L., et al.
Publicado: (2016)

Enhanced Myogenic Constriction in the SHR Preglomerular Vessels Is Mediated by Thromboxane A2 Synthesis
por: Nademi, Samera, et al.
Publicado: (2020)

Diverse associations between oxidative stress and thromboxane A(2) in hypertensive glomerular injury
por: Nakano, Yukihito, et al.
Publicado: (2018)

Varying levels of 6-keto-prostaglandin F1α and thromboxane B(2) in serum and endothelialization and hyperplasia in small-diameter grafts seeded with CD34+ bone marrow cells in canines
por: LIAN, WEISHUAI, et al.
Publicado: (2014)

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload
por: Mulvaney, Eamon P., et al.
Publicado: (2022)

Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer’s model
por: Wallace, Charles H, et al.
Publicado: (2022)

ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction
por: Trigani, Kevin T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ephp25pnnstp81b62rj6jshkcm